Primary Central Nervous System Lymphoma: Time to ask the question

Journal of Clinical Oncology

Volumn 20, Issue 24, 2002, Pages 4615-4617

  Fine, Howard A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; METHOTREXATE; PROCARBAZINE; VINCRISTINE;

ANTINEOPLASTIC ACTIVITY; BLOOD BRAIN BARRIER; BRAIN TUMOR; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CONTRAST ENHANCEMENT; EDITORIAL; HUMAN; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; PRIORITY JOURNAL; PROPHYLAXIS; QUALITY OF LIFE; WHOLE BODY RADIATION;

EID: 0037115428     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2002.20.24.4615     Document Type: Editorial

References (6)

1. DeAngelis LM, Seiferheld W, Schold SC, et al: Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10. J Clin Oncol 20:4643-4648, 2002
2. Abrey LE, Yahalom J, DeAngelis LM: Treatment for primary CNS lymphoma: The next step. J Clin Oncol 18:3144-3150, 2000
3. Hochberg FH, Tabatabai G: Therapy of PCNSL at the Massachusetts General Hospital with high dose methotrexate and deferred radiotherapy. Ann Hematol 80:B111-B112, 2001 (suppl 3)
4. Batchelor TT, Hochberg F, O'Neill A, et al: The treatment of primary central nervous system lymphoma (PCNSL) with methotrexate and deferred radiotherapy: NABTT 96-07. Proc Am Soc Clin Oncol 19:159a, 2000 (abstr 616)
5. Henson JW, Yang J, Batchelor T: Intraocular methotrexate level after high-dose intravenous infusion. J Clin Oncol 17:1329, 1999 (letter)
6. Alizadeh AA, Eisen MB, Davis RE, et al: Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403:503-511, 2000